BR vs MIRM · P/E 16, rev $6.89B vs rev $336.9M
Broadridge Financial Solutions Inc (BR) versus Mirum Pharmaceuticals Inc (MIRM) — a side-by-side from cached financials, not a winner call.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
Latest reported BR revenue for 2025-06-30 was $6.89B. Net income was $839.5M. Revenue was up 5.9% from 2024-06-30 to 2025-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Latest reported MIRM revenue for 2024-12-31 was $336.9M. Net income was -$87.9M. Revenue was up 80.8% from 2023-12-31 to 2024-12-31. MIRM currently screens at market cap $6.22B.
BR currently screens at market cap $17.65B and trailing P/E 16.3. MIRM currently screens at market cap $6.22B.
Not investment advice. Open the BR and MIRM stock pages for the full models.
Not investment advice.